KRIT1 in vascular biology and beyond
Bioscience Reports · 31.07.2024 · 44 (7)
DOI: 10.1042/bsr20231675 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioscience Reports, online erschienen am 19.07.2024. Verfasst von Angela J Glading. Beteiligte Einrichtung: Department of Pharmacology and Physiology, University of Rochester, Rochester, NY, U.S.A. Hauptthemen laut MEDLINE: KRIT1 Protein, Hemangioma, Cavernous, Central Nervous System, Endothelial Cells. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute (NHLBI).
Abstract (Originalsprache)
KRIT1 is a 75 kDa scaffolding protein which regulates endothelial cell phenotype by limiting the response to inflammatory stimuli and maintaining a quiescent and stable endothelial barrier. Loss-of-function mutations in KRIT1 lead to the development of cerebral cavernous malformations (CCM), a disease marked by the formation of abnormal blood vessels which exhibit a loss of barrier function, increased endothelial proliferation, and altered gene expression. While many advances have been made in our understanding of how KRIT1, and the functionally related proteins CCM2 and PDCD10, contribute to the regulation of blood vessels and the vascular barrier, some important open questions remain. In addition, KRIT1 is widely expressed and KRIT1 and the other CCM proteins have been shown to play important roles in non-endothelial cell types and tissues, which may or may not be related to their role as pathogenic originators of CCM. In this review, we discuss some of the unsettled questions regarding the role of KRIT1 in vascular physiology and discuss recent advances that suggest this ubiquitously expressed protein may have a role beyond the endothelial cell.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Physiology, University of Rochester, Rochester, NY, U.S.A.
ORCID-Profile: Angela J Glading
Förderung
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute (NHLBI)
Zitieren
APA
Glading, A. J. (2024). KRIT1 in vascular biology and beyond. Bioscience Reports, 44(7). https://doi.org/10.1042/bsr20231675
Vancouver
Glading AJ. KRIT1 in vascular biology and beyond. Bioscience Reports. 2024;44(7). doi:10.1042/bsr20231675
BibTeX
@article{Glading2024,
author = {Glading, Angela J},
title = {KRIT1 in vascular biology and beyond},
journal = {Bioscience Reports},
year = {2024},
volume = {44},
number = {7},
doi = {10.1042/bsr20231675}
}
EUVIMED